Potential applications of biomarkers of radiation exposure in nuclear terrorism events

Physica Medica

Volumn 19, Issue 3, 2003, Pages 191-212

  Durante, Marco ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

Author keywords

Biodosimetry; Biomarkers; Nuclear weapons; Radiological terrorism

Indexed keywords

BIOLOGICAL MARKER; RADIOACTIVE MATERIAL;

ATOMIC BOMB; ATOMIC WARFARE; AUTOANALYSIS; BLOOD CELL COUNT; CHERNOBYL ACCIDENT; CHROMOSOME PAINTING; COMET ASSAY; COMPUTER PROGRAM; CYTOGENETICS; DIAGNOSTIC TEST; DNA DAMAGE; DOSIMETRY; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION; HUMAN; IMMUNOHISTOCHEMISTRY; MEASUREMENT; MICRONUCLEUS TEST; MOLECULAR BIOLOGY; MORTALITY; NUCLEAR POWER PLANT; PREMATURE CHROMOSOME CONDENSATION; RADIATION DOSE; RADIATION EXPOSURE; RADIATION HAZARD; RADIATION RESPONSE; RADIATION SICKNESS; RADIOACTIVITY; RELIABILITY; REVIEW; RISK ASSESSMENT; SCREENING TEST; SOMATIC MUTATION; TECHNIQUE; TERRORISM; VALIDATION PROCESS; WATER CONTAMINATION;

EID: 0242354079     PISSN: 11201797     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (139)

1. Jenkins B. Will Terrorists Go Nuclear? Los Angeles. Crescent Publications 1975.
2. st Century. New York. St. Martin's Press 1999.
3. Brackett DW. Holy terror: Armageddon in Tokyo. New York. Weatherhill 1996.
4. Glasstone S, Dolan PJ. The Effects of Nuclear Weapons. Washington DC. US Departments of Defense and Department of Energy 1977.
5. Chapin DM, Cohen KP, Davis WK, Kintner EE, Koch LJ, Landis JW, Levenson M, Mandil IH, Pate ZT, Rockwell T, Schriesheim A, Simpson JW, Squire A, Starr C, Stone HE, Taylor JJ, Todreas NE, Wolfe B, Zebroski EL. Nuclear safety. Nuclear power plants and their fuel as terrorist targets. Science 2002: 297; 1997-1999.
6. Von Hippel FN. Revisiting nuclear power plant safety. Science 2003: 299; 201.
7. Brenner DJ. Revisiting nuclear power plant safety. Science 2003: 299; 201-202.
8. US Nuclear Regulatory Commission. Technical study of spent fuel pool accident risk at decommissioning nuclear power plants. Washington DC. NUREG-1738, NRC 2001.
9. Lubenau JO, Strom DJ. Safety and security of radiation sources in the aftermath of 11 September 2001. Health Phys 2002: 83; 155-164.
10. NCRP (National Council on Radiation Protection and Measurements). Management of terrorist events involving radioactive material. NCRP report no. 138. Bethesda (MD) 2001.
11. Sutcliffe WG, Condit RH, Mansfield WG, Myers DS, Layton DW, Murphy PW. A perspective on the dangers of plutonium. UCRL-JC-118825/CSTS-48-95, Lawrence Livermore National Laboratory (CA) 1995.
12. ICRP. (International Commission on Radiological Protection). Recommendations of the International Commission on Radiological Protection. Annals of the ICRP. Publication 60 1991: 21.
13. Committee on Dosimetry for RERF. Status of the dosimetry for the Radiation Effects Research Foundation (DS86). Washington DC. National Academy Press 2001.
14. Shigematsu I. Lessons from atomic bomb survivors in Hiroshima and Nagasaki. Health Phys 2000: 79; 234-241.
15. NCRP (National Council on Radiation Protection and Measurements). Limitation of exposure to ionizing radiation. NCRP report no. 116. Bethesda (MD) 1993.
16. Ferlic KP, McManaman VL. Nuclear weapons fallout. In: Military Radiobiology. Conklin JJ and Walker RI Eds. San Diego. Academic Press 1987; 25-53.
17. ICRP (International Commission on Radiological Protection). Limits for intakes of radionuclides by workers. Annals of the ICRP. Publication 30 Part I (supplement), vol 2. 1980: 4.
18. UNSCEAR Sources and Effects of Ionizing Radiation. Vol. II, Annex J, Exposure and effects of the Chernobyl accident. New York. United Nations 2000.
19. Kellerer AM. Invisible threat: the risk of ionizing radiation. In: Nuclear Science in Europe: Impact, Applications, Interactions. Guerrau D, Aysto J, Guillemaud-Mueller D and Korner GE Eds. Paris NuPECC 2002; 59-174.
20. Durante M, Manti L. Estimates of radiological risk from a terrorist attack using plutonium. Radiat Environ Biophys 2002: 41; 125-130.
21. NCRP (National Council on Radiation Protection and Measurements). Use of bioassay procedures for assessment of internal radionuclide deposition. NCRP report no. 87 Bethesda (MD) 1987.
22. Brooks AL. Biomarkers of exposure, sensitivity and disease. Int J Radiat Biol 1999: 75; 1481-503.
23. Brooks AL. Biomarkers of exposure and dose: state of the art. Radiat Prot Dosim 2001: 97; 39-46.
24. Bonassi S, Au WW. Biomarkers in molecular epidemiology studies for health risk prediction. Mutat Res 2002: 511; 73-86.
25. Bonassi S, Neri M, Puntoni R. Validation of biomarkers as early predictors of disease. Mutat Res 2001: 480-481; 349-358.
26. Baranov AE, Guskova AK, Nadejina NM, Nugis VYu. Chernobyl experience: biological indicators of exposure to ionizing radiation. Stem Cells 1995: 13; S69-S77.
27. Goans RE, Holloway EC, Berger ME, Ricks RC. Early dose assessment following severe radiation accidents. Health Phys 1997: 72; 513-518.
28. Greenstock CL, Trivedi A. Biological and biophysical techniques to assess radiation exposure: a perspective. Prog Biophys Mol Biol 1994: 61; 81-130.
29. IAEA (International Atomic Energy Agency). Cytogenetic analysis for radiation dose assessment. IAEA Technical report no. 405. Vienna 2001.
30. Kamiguchi Y, Tateno H. Radiation- and chemical-induced structural chromosome aberrations in human spermatozoa. Mutat Res 2002: 504; 183-191.
31. Belien JA, Copper MP, Braakhuis BJ, Snow GB, Baak JP. Standardization of counting micronuclei: definition of a protocol to measure genotoxic damage in human exfoliated cells. Carcinogenesis 1995: 16; 2395-2400.
32. Bender MA, Awa AA, Brooks AL, Evans HJ, Groer PG, Littlefield LG, Pereira C, Preston RJ, Wachholz BW. Current status of cytogenetic procedures to detect and quantify previous exposures to radiation. Mutat Res 1988: 196; 103-159.
33. Edwards AA. The use of chromosomal aberrations in human lymphocytes for biological dosimetry. Radiat Res 1997: 148; S39-S44.
34. Dossou J, Lartigau E, M'Kacher R, Légal JD, Bridier A, Guichard M, Eschwege F, Parmentier C. Biological dosimetry after total body irradiation (TBI) for hematologic malignancy patients. Int J Radiat Oncol Biol Phys 2000: 46; 123-129.
35. Lloyd DC, Edwards AA, Leonard A, Deknudt GL, Verschaeve L, Natarajan AT, Darroudi F, Obe G, Palitti F, Tanzarella C, Tawn EJ. Chromosomal aberrations in human lymphocytes induced in vitro by very low doses of X-rays. Int J Radiat Biol 1992: 61; 335-343.
36. Norman A, Sasaki MS. Chromosome-exchange aberrations in human lymphocytes. Int J Radiat Biol 1966: 11; 321-328.
37. Tucker JD. FISH cytogenetics and the future of radiation biodosimetry. Radiat Prot Dosim 2001: 97; 55-60.
38. Lucas JN. Dose reconstruction for individuals exposed to ionizing radiation using chromosome painting. Radiat Res 1997: 148; S33-S38.
39. Nakano M, Kodama Y, Ohtaki K, Itoh M, Delongchamp R, Awa AA, Nakamura N. Detection of stable chromosome aberrations by FISH in A-bomb survivors: comparison with previous solid Giemsa staining data on the same 230 individuals. Int J Radiat Biol 2001: 77; 971-977.
40. Fenech M, Holland N, Chang WP, Zeiger E, Bonassi S. The HUman MicroNucleus Project - An international collaborative study on the use of the micronucleus technique for measuring DNA damage in humans. Mutat Res 1999: 428; 271-283.
41. Fenech M, Bonassi S, Turner J, Lando C, Ceppi M, Chang WP, Holland N, Kirsch-Volders M, Zeiger E, Bigatti MP, Bolognesi C, Cao J, De Luca G, Di Giorgio M, Ferguson LR, Fucic A, Lima OG, Hadjidekova W, Hrelia P, Jaworska A, Joksic G, Krishnaja AP, Lee TK, Martelli A, McKay MJ, Migliore L, Mirkova E, Muller WU, Odagiri Y, Orsiere T, Scarfi MR, Silva MJ, Sofuni T, Suralles J, Trenta G, Vorobtsova I, Vral A, Zijno A. Intra- and inter-laboratory variation in the scoring of micronuclei and nucleoplasmic bridges in binucleated human lymphocytes. Results of an international slide-scoring exercise by the HUMN project. Mutat Res 2003: 534; 45-64.
42. Durante M, George K, Yang TC. Biodosimetry of ionizing radiation by selective painting of prematurely condensed chromosomes in human lymphocytes. Radiat Res 1997: 148; S45-S50.
43. Durante M, Yamada S, Ando K, Furusawa Y, Kawata T, Majima H, Nakano T, Tsujii H. Measurements of the equivalent whole-body dose during radiation therapy by cytogenetic methods. Phys Med Biol 1999: 44; 1289-1298.
44. Scholz M, Kraft-Weyrather W, Ritter S, Kraft G. Cell cycle delays induced by heavy ion irradiation of synchronous mammalian cells. Int J Radiat Biol 1994: 66; 59-75.
45. Pantelias GE, Maillie HD. The use of peripheral blood mononuclear cell prematurely condensed chromosomes for biological dosimetry. Radiat Res 1984: 99; 140-150.
46. Durante M, Furusawa Y, Gotoh E. A simple method for simultaneous interphase-metaphase chromosome analysis in biodosimetry. Int J Radiat Biol 1998: 74; 457-462.
47. Gotoh E, Asakawa Y. Detection and evaluation of chromosomal aberrations induced by high doses of gamma-irradiation using immunogold-silver painting of prematurely condensed chromosomes. Int J Radiat Biol 1996: 70, 517-520.
48. Stronati L, Durante M, Gensabella G, Gialanella G, Grossi GF, Pugliese M, Scampoli, P, Sgura A, Testa A, Tanzarella C. Calibration curves for biological dosimetry by fluorescence in situ hybridisation. Radiat Prot Dosim 2001: 94; 335-345.
49. Kanda R, Hayata I, Lloyd DC. Easy biodosimetry for high-dose radiation exposures using drug-induced, prematurely condensed chromosomes. Int J Radiat Biol 1999: 75; 441-446.
50. Prasanna PG, Escalada ND, Blakely WF. Induction of premature chromosome condensation by a phosphatase inhibitor and a protein kinase in unstimulated human peripheral blood lymphocytes: a simple and rapid technique to study chromosome aberrations using specific whole-chromosome DNA hybridization probes for biological dosimetry. Mutat Res 2000: 466; 131-141.
51. Olive PL. The comet assay. An overview of techniques. Methods Mol Biol 2002: 203; 179-194.
52. Vijayalaxmi, Tice RR, Strauss GH. Assessment of radiation-induced DNA damage in human blood lymphocytes using the single-cell gel electrophoresis technique. Mutat Res 1992: 271; 243-252.
53. Garaj-Vrhovac V, Kopjar N, Razem D, Vekic B, Miljanic S, Ranogajec-Komor M. Application of the alkaline comet assay in biodosimetry: assessment of in vivo DNA damage in human peripheral leukocytes after a gamma radiation incident. Radiat Prot Dosim 2002: 98; 407-416.
54. Sutherland BM, Bennett PV, Saparbaev M, Sutherland JC, Laval J. Clustered DNA damages as dosemeters for ionising radiation exposure and biological responses. Radiat Prot Dosim 2001: 97; 33-38.
55. Sutherland BM, Bennett PV, Sidorkina O, Laval J. Clustered DNA damages induced in isolated DNA and in human cells by low doses of ionizing radiation. Proc Natl Acad Sci USA 2000: 97; 103-108.
56. Rogakou EP, Pilch DR, Orr AH, Ivanova VS, Bonner WM. DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 1998: 273; 5858-5868.
57. Rogakou EP, Boon C, Redon C, Bonner WM. Megabase chromatin domains involved in DNA double-strand breaks in vivo. J Cell Biol 1999: 146; 905-916.
58. Sedelnikova OA, Rogakou EP, Panyutin IG, Bonner WM. Quantitative detection of (125)IdU-induced DNA double-strand breaks with γ-H2AX antibody. Radiat Res 2002: 158; 486-492.
59. Rothkamm K, Lobrich M. Evidence for a lack of DNA double-strand break repair in human cells exposed to very low X-ray doses. Proc Natl Acad Sci USA 2003: 100; 5057-5062.
60. Bonner WM. Low-dose radiation: thresholds, bystander effects, and adaptive responses. Proc Natl Acad Sci USA 2003: 100; 4973-4975.
61. Jensen RH, Bigbee WL, Langlois RG. Multiple end-points for somatic mutations in humans provide complementary views for biodosimetry, genotoxicity and health risks. Prog Clin Biol Res 1990: 340C; 81-92.
62. Amundson SA, Bittner M, Meltzer P, Trent J, Fornace AJ Jr. Biological indicators for the identification of ionizing radiation exposure in humans. Expert Rev Mol Diagn 2001: 1; 211-219.
63. Langlois RG, Bigbee WL, Jensen RH. The glycophorin A assay for somatic cell mutations in humans. Prog Clin Biol Res 1990: 340C; 47-56.
64. Montero R, Gonsebatt ME, Herrera LA, Rojas E, Ostrosky-Wegman P. The HPRT short-term assay in monitoring individuals exposed to genotoxic agents. Environ Health Perspect 1993: 101; S135-S138.
65. Jones IM, Galick H, Kato P, Langlois RG, Mendelsohn ML, Murphy GA, Pleshanov P, Ramsey MJ, Thomas CB, Tucker JD, Tureva L, Vorobtsova I, Nelson DO. Three somatic genetic biomarkers and covariates in radiation-exposed Russian cleanup workers of the Chernobyl nuclear reactor 6-13 years after exposure. Radiat Res 2002: 158; 424-442.
66. Amundson SA, Fornace AJ Jr. Gene expression profiles for monitoring radiation exposure. Radiat Prot Dosim 2001: 97; 11-16.
67. Amundson SA, Bittner M, Meltzer P, Trent J, Fornace AJ Jr. Induction of gene expression as a monitor of exposure to ionizing radiation. Radiat Res 2001: 156; 657-661.
68. Holland PM, Abramson RD, Watson R, Gelfand DH. Detection of specific polymerase chain reaction product by utilizing the 5′-3′ exonuclease activity of Thermus aquaticus DNA polymerase. Proc Natl Acad Sci USA 1991: 88; 7276-7280.
69. Blakely WF, Prasanna PG, Grace MB, Miller AC. Radiation exposure assessment using cytological and molecular biomarkers. Radiat Prot Dosim 2001: 97; 17-23
70. Miller AC, Luo L, Chin WK, Director-Myska AE, Prasanna PG, Blakely WF. Proto-oncogene expression: a predictive assay for radiation biodosimetry applications. Radiat Prot Dosim 2002: 99; 295-302.
71. Grace MB, McLeland CB, Blakely WF. Real-time quantitative RT-PCR assay of GADD45 gene expression changes as a biomarker for radiation biodosimetry. Int J Radiat Biol 2002: 78; 1011-1021.
72. ICRU (International Commission on Radiation Units and measurements). Retrospective Assessment of Exposures to Ionizing Radiation, Report 68. Journal of the ICRU 2002: 2 (2).
73. Regulla DF, Deffner U. Dose estimation by ESR spectroscopy at a fatal radiation accident. Appl Radiat Isot 1989: 40; 1039-1043.
74. Romanyukha AA, Nagy V, Sleptchonok O, Desrosiers MF, Jiang J, Heiss A. Individual biodosimetry at the natural radiation background level. Health Phys 2001: 80; 71-73.
75. Nakamura N, Miyazawa C, Sawada S, Akiyama M, Awa AA. A close correlation between electron spin resonance (ESR) dosimetry from tooth enamel and cytogenetic dosimetry from lymphocytes of Hiroshima atomic-bomb survivors. Int J Radiat Biol 1998: 73; 619-627.
76. Nakamura N, Katanic JF, Miyazawa C. Contamination from possible solar light exposures in ESR dosimetry using human tooth enamel. J Radiat Res 1998: 39; 185-191.
77. Ikeya M, Ishii H. Atomic bomb and accident dosimetry with ESR: natural rocks and human tooth in vivo spectrometer. Appl Radiat Isot 1989: 40; 1021-1027.
78. Yamanaka C, Ikeya M, Hara H. ESR cavities for in vivo dosimetry of tooth enamel. Appl Radiat Isot 1993: 44; 77-80.
79. Hankins DE. Dosimetry of criticality accidents using activations of the blood and hair. Health Phys 1980: 38; 529-541.
80. Tanaka SI. Summary of the JCO criticality accident in Tokai-mura and a dose assessment. J Radiat Res 2001: 42; S1-S9.
81. 24Na activity in the human body at the JCO criticality accident in Tokai-mura. J Radiat Res 2001: 42; S95-S105.
82. IAEA (International Atomic Energy Agency). Dosimetry for criticality accidents. IAEA Technical report no. 251, Vienna 1982
83. Takeda H, Miyamoto K, Yukawa M, Nishimura Y, Watanabe Y, Kim HS, Fuma S, Kuroda N, Kouno F, Joshima H, Hirama T, Akashi M. Bioassay for neutron-dose estimations of three patients in the JCO criticality accident in Tokai-mura by measuring β-ray emitters. J Radiat Res 2001: 42; S129-S135.
84. Voisin P, Assaei RG, Heidary A, Varzegar R, Zakeri F, Durand V, Sorokine-Durm I. Mathematical methods in biological dosimetry: the 1996 Iranian accident. Int J Radiat Biol 2000: 76; 1545-1554.
85. Sasaki MS, Miyata H. Biological dosimetry in atomic bomb survivors. Nature 1968: 220; 1189-1193.
86. Ekstrand KE, Plunkett S, Heise ER, Dixon RL, Raben M. Lymphocyte migration and radiation lymphopenia. Int J Radiat Oncol Biol Phys 1981: 7; 1451-1455.
87. Légal JD, De Crevoisier R, Lartigau E, Morsli K, Dossou J, Chavaudra N, Sanfilippo N, Bourhis J, Eschwege F, Parmentier C. Chromosomal aberrations induced by chemotherapy and radiotherapy in lymphocytes from patients with breast carcinoma. Int J Radiat Oncol Biol Phys 2002: 52; 1186-1195.
88. Moulder JE. Radiobiology of nuclear terrorism: report on an interagency workshop (Bethesda, MD, December 17-18, 2001). Int J Radiat Oncol Biol Phys 2002: 54; 327-328.
89. Moulder JE. Report on an interagency workshop on the radiobiology of nuclear terrorism. Molecular and cellular biology dose (1-10 Sv) radiation and potential mechanisms of radiation protection. Radiat Res 2002: 158; 118-124.
90. Sharan RN. Preparedness to respond to possible acts of nuclear terrorism: some strategies and recommendations. Int J Radiat Biol 2003: 79; 217-219.
91. Mettler FA Jr, Voelz GL. Major radiation exposure, what to expect and how to respond. N Engl J Med 2002: 346; 1554-1561.
92. Hogan DE, Kellison T. Nuclear terrorism. Am J Med Sci 2002: 323; 341-349.
93. Edwards AA, Lloyd DC. Risks from ionising radiation: deterministic effects. J Radiol Prot 1998: 18; 175-183.
94. Baranov A, Gale RP, Guskova A, Piatkin E, Selidovkin G, Muravyova L, Champlin RE, Danilova N, Yevseeva L, Petrosyan L. Bone marrow transplantation after the Chernobyl nuclear accident. N Engl J Med 1989: 32; 205-212.
95. Kanda R, Minamihisamatsu M, Hayata I. Dynamic analysis of chromosome aberrations in three victims of the Tokai-mura criticality accident. Int J Radiat Biol 2002: 78; 857-862.
96. Ishigure N, Endo A, Yamaguchi Y, Kawachi K. Calculation of the absorbed dose for the overexposed patients at the JCO criticality accident in Tokai-mura. J Radiat Res 2001: 42; S137-S148.
97. Livingston GK, Jensen RH, Silberstein EB, Hinnefeld JD, Pratt G, Bigbee WL, Langlois RG, Grant SG, Shukla R. Radiobiological evaluation of immigrants from the vicinity of Chernobyl. Int J Radiat Biol 1997: 72; 703-713.
98. Sasaki MS, Hayata I, Kamada N, Kodama Y, Kodama S. Chromosome aberration analysis in persons exposed to low-level radiation from the JCO criticality accident in Tokai-mura. J Radiat Res 2001: 42; S107-S116.
99. Woloschak GE, Chang-Liu CM. Modulation of expression of genes encoding nuclear proteins following exposure to JANUS neutrons or γ-rays. Cancer Lett 1995: 97; 169-175.
100. Deng W, Morrison DP, Gale KL, Lucas JN. A comparative study on potential cytogenetic fingerprints for radiation LET in human lymphocytes. Int J Radiat Biol 2000: 76; 1589-1598.
101. Nakamura N, Tucker JD, Bauchinger M, Littlefield LG, Lloyd DC, Preston RJ, Sasaki MS, Awa AA, Wolff S. F values as cytogenetic fingerprints of prior exposure to different radiation qualities: prediction, reality and future. Radiat Res 1998; 150: 492-494.
102. Lucas JN, Deng W, Oram SW, Hill FS, Durante M, George K, Wu H, Owens CL, Yang TC. Theoretical and experimental tests of a chromosomal fingerprint for densely ionizing radiation based on F ratios calculated from stable and unstable chromosome aberrations. Radiat Res 1999: 151; 85-91.
103. Savage JR, Simpson PJ. FISH "painting" patterns resulting from complex exchanges. Mutat Res 1994: 312; 51-60.
104. Anderson RM, Marsden SJ, Wright EG, Kadhim MA, Goodhead DT, Griffin CS. Complex chromosome aberrations in peripheral blood lymphocytes as a potential biomarker of exposure to high-LET alpha-particles. Int J Radiat Biol 2000: 76; 31-42.
105. Durante M, Furusawa Y, George K, Gialanella G, Greco O, Grossi G, Matsufuji N, Pugliese M, Yang TC. Rejoining and misrejoining of radiation-induced chromatin breaks. IV. Charged particles. Radiat Res 1998: 149; 446-454.
106. Anderson RM, Stevens DL, Goodhead DT. M-FISH analysis shows that complex chromosome aberrations induced by α-particle tracks are cumulative products of localized rearrangements. Proc Natl Acad Sci USA 2002: 99; 12167-12172.
107. Darroudi F, Bezrookove V, Fomina J, Mesker WE, Wiegant JC, Raap AK, Tanke HJ. Insights into the sites of X-ray and neutron induced chromosomal aberrations in human lymphocytes using COBRA-MFISH. Radiat Prot Dosim 2002: 99; 189-192.
108. Durante M, George K, Wu H, Cucinotta FA. Karyotypes of human lymphocytes exposed to high-energy iron ions. Radiat Res 2002: 158; 581-590.
109. Durante M. Biological dosimetry in astronauts. Riv Nuovo Cimento 1996: 19(12); 1-44.
110. Testard I, Sabatier L. Biological dosimetry for astronauts: a real challenge. Mutat Res 1999: 430; 315-326.
111. Durante M, Bonassi S, George K, Cucinotta FA. Risk estimation based on chromosomal aberrations induced by radiation. Radiat Res 2001: 156; 662-667.
112. George K, Durante M, Wu H, Willingham V, Badhwar G, Cucinotta FA. Chromosome aberrations in the blood lymphocytes of astronauts after space flight. Radiat Res 2001: 156; 731-738.
113. Durante M, Yamada S, Ando K, Furusawa Y, Kawata T, Majima H, Nakano T, Tsujii H X-rays vs. carbon-ion tumor therapy: cytogenetic damage in lymphocytes. Int J Radiat Oncol Biol Phys 2000: 47; 793-798.
114. Yamada S, Durante M, Ando K, Furusawa Y, Kawata T, Majima H, Tsujii H. Complex-type chromosomal exchanges in blood lymphocytes during radiation therapy correlate with acute toxicity. Cancer Lett 2000: 150; 215-221.
115. Brenner DJ, Sachs RK. Chromosomal "fingerprints" of prior exposure to densely ionizing radiation. Radiat Res 1994: 140; 134-142.
116. Johannes C, Chudoba I, Obe G. Analysis of X-ray-induced aberrations in human chromosome 5 using high-resolution multicolour banding FISH (mBAND). Chromosome Res 1999: 7; 625-633.
117. Hande MP, Azizova TV, Geard CR, Burak LE, Mitchell CR, Khokhryakov VF, Vasilenko EK, Brenner DJ. Past exposure to densely ionizing radiation leaves a unique permanent signature in the genome. Am J Hum Genet 2003: 72; 1162-1170.
118. Finnon P, Lloyd DC, Edwards AA. An assessment of the metaphase finding capability of the Cytoscan 110. Mutat Res 1986: 164; 101-108.
119. Castleman KR. The PSI automatic metaphase finder. J Radiat Res 1992: 33; S124-S128.
120. Weber J, Scheid W, Traut H. Time-saving in biological dosimetry by using the automatic metaphase finder Metafer2. Mutat Res 1992: 272; 31-34.
121. Huber R, Lorch T, Kulka U, Braselmann H, Bauchinger M. Automated classification of first and second cycle metaphases. Mutat Res 1998: 419; 27-32.
122. Bayley R, Carothers A, Chen X, Farrow S, Gordon J, Ji L, Piper J, Rutovitz D, Stark M, Wald N. Radiation dosimetry by automatic image analysis of dicentric chromosomes. Mutat Res 1992: 253; 223-235.
123. Yamamoto M, Hayata I, Furuta S. A high resolution chromosome image processor for study purposes, NIRS-1000:CHROMO STUDY, and algorithm developing to classify radiation induced aberrations. J Radiat Res 1992: 33; S129-S151.
124. Finnon P, Lloyd D. A preliminary evaluation of the Edinburgh dicentric hunter. J Radiat Res 1992: 33; S215-S221.
125. Blakely WF, Prasanna PG, Kolanko CJ, Pyle MD, Mosbrook DM, Loats AS, Rippeon TL, Loats H. Application of the premature chromosome condensation assay in simulated partial-body radiation exposures: evaluation of the use of an automated metaphase-finder. Stem Cells 1995: 13; S223-S230.
126. Thierens H, Vral A, De Scheerder F, De Ridder L, Tates A. Semi-automated micronucleus scoring in cytokinesis-blocked lymphocytes after irradiation. Int J Radiat Biol 1997: 72; 319-324.
127. Parton JW, Hoffman WP, Garriott ML. Validation of an automated image analysis micronucleus scoring system. Mutat Res 1996; 370: 65-73.
128. Schreiber GA, Beisker W, Braselmann H, Bauchinger M, Bogl KW, Nusse M. An automated flow cytometric micronucleus assay for human lymphocytes. Int J Radiat Biol 1992: 62; 695-709.
129. Smolewski P, Ruan Q, Vellon L, Darzynkiewicz Z. Micronuclei assay by laser scanning cytometry. Cytometry 2001: 45; 19-26.
130. Huber R, Kulka U, Lorch T, Braselmann H, Engert D, Figel M, Bauchinger M. application of the Metafer2 fluorescence scanning system for the analysis of radiation-induced chromosome aberrations measured by FISH-chromosome painting. Mutat Res 2001: 492; 51-57.
131. Mascio LN, Yuen BK, Kegelmeyer WP Jr, Matsumoto K, Briner J, Wyrobek AJ. Advances in the automated detection of metaphase chromosomes labeled with fluorescence dyes. Cytometry 1998: 33; 10-18.
132. Castleman KR, Schulze M, Wu Q. Automated biodosimetry using digital image analysis of fluorescence in situ hybridization specimens. Radiat Res 1997: 148; S71-S75.
133. Fantes JA, Green DK, Hill W, Stark MH, Gordon JM, Piper J. Application of automation to the detection of radiation damage using FISH technology. Int J Radiat Biol 1995: 68; 263-276.
134. nd Annual Meeting of the European Society for Radiation Biology, Liege, September 4-7, 2002.
135. Blakely WF, Brooks AL, Lofts RS, van der Schans GP, Voisin P. Overview of low-level radiation exposure assessment: biodosimetry. Mil Med 2002: 167; S20-S24.
136. Sine RC, Levine IH, Jackson WE, Hawley AL, Prasanna PG, Grace MB, Goans RE, Greenhill RG, Blakely WF. Biodosimety Assessment Tool: a post-exposure software application for management of radiation accidents. Mil Med 2001: 166; S85-S87.
137. AFRRI. Biodosimetry Assessment Tool (BAT). http://www.afrri.usuhs.mil/bat/
138. Anno GH, Baum SJ, Withers HR, Young RW. Symptomatology of acute radiation effects in humans after exposure to doses of 0.5-30 Gy. Heakh Phys 1989: 56; 821-838.
139. AFRRI. Medical Management of Radiation Casualties. AFRRI Special Publication 03-1, Bethesda (MD) 2003.